Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Baxter
Moodys
Accenture
Johnson and Johnson
Federal Trade Commission
US Department of Justice
QuintilesIMS
McKinsey

Generated: December 15, 2018

DrugPatentWatch Database Preview

Pseudoephedrine hydrochloride; triprolidine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for pseudoephedrine hydrochloride; triprolidine hydrochloride and what is the scope of pseudoephedrine hydrochloride; triprolidine hydrochloride patent protection?

Pseudoephedrine hydrochloride; triprolidine hydrochloride is the generic ingredient in twelve branded drugs marketed by Glaxosmithkline, Kv Pharm, Cenci, Usl Pharma, Newtron Pharms, Pvt Form, Fosun Pharma, Sandoz, Teva, Watson Labs, West Ward, Ivax Sub Teva Pharms, and Superpharm, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-nine drug master file entries for pseudoephedrine hydrochloride; triprolidine hydrochloride.

Summary for pseudoephedrine hydrochloride; triprolidine hydrochloride
US Patents:0
Tradenames:12
Applicants:13
NDAs:16
Drug Master File Entries: 49
DailyMed Link:pseudoephedrine hydrochloride; triprolidine hydrochloride at DailyMed

US Patents and Regulatory Information for pseudoephedrine hydrochloride; triprolidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs TRIPROLIDINE AND PSEUDOEPHEDRINE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088318-002 Jan 13, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ivax Sub Teva Pharms TRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 085273-001 Dec 12, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Newtron Pharms TRILITRON pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088515-001 Jan 9, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pvt Form ALLERFED pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088860-001 Jan 31, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline ACTIFED pseudoephedrine hydrochloride; triprolidine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 018996-001 Jun 17, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Superpharm TRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088578-001 Feb 21, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Baxter
Moodys
Accenture
Johnson and Johnson
Federal Trade Commission
US Department of Justice
QuintilesIMS
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.